Catecholaminergic polymorphic ventricular tachycardia differential diagnosis: Difference between revisions
No edit summary |
|||
Line 9: | Line 9: | ||
==Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases== | ==Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases== | ||
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause [[syncope]], [[ventricular tachycardia]], and [[sudden cardiac death]], such as: | Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause [[syncope]], [[ventricular tachycardia]], and [[sudden cardiac death]], such as:<ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1289/ |title=Catecholaminergic Polymorphic Ventricular Tachycardia - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}<ref/><ref name="YlänenPoutanen2010">{{cite journal|last1=Ylänen|first1=Kaisa|last2=Poutanen|first2=Tuija|last3=Hiippala|first3=Anita|last4=Swan|first4=Heikki|last5=Korppi|first5=Matti|title=Catecholaminergic polymorphic ventricular tachycardia|journal=European Journal of Pediatrics|volume=169|issue=5|year=2010|pages=535–542|issn=0340-6199|doi=10.1007/s00431-010-1154-2}}</ref> | ||
*[[Arrhythmogenic right ventricular dysplasia]] | *[[Arrhythmogenic right ventricular dysplasia]] | ||
*Short-coupled [[ventricular tachycardia]] (SC-[[torsade de pointes]] [TdP]) | *Short-coupled [[ventricular tachycardia]] (SC-[[torsade de pointes]] [TdP]) | ||
Line 31: | Line 31: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''ECG during exercise or stress''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''ECG during exercise or stress''' | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;"[[Catecholaminergic polymorphic ventricular tachycardia]] | | style="background: #DCDCDC; padding: 5px; text-align: center;"|[[Catecholaminergic polymorphic ventricular tachycardia]] | ||
| style="background: #F5F5F5; padding: 5px;" |[[Mutation]]s in [[Ryanodine receptor 2|RYR2]] and [[Calsequestrin|CASQ2]] [[gene|genes]] | | style="background: #F5F5F5; padding: 5px;" |[[Mutation]]s in [[Ryanodine receptor 2|RYR2]] and [[Calsequestrin|CASQ2]] [[gene|genes]] | ||
|style="background: #F5F5F5; padding: 5px;" |Symptoms are exercise or emotion related | |style="background: #F5F5F5; padding: 5px;" |Symptoms are exercise or emotion related | ||
Line 157: | Line 157: | ||
(SC-[[torsade de pointes]] [[TdP]]) | (SC-[[torsade de pointes]] [[TdP]]) | ||
| style="background: #F5F5F5; padding: 5px;" |Unknown | | style="background: #F5F5F5; padding: 5px;" |Unknown | ||
| style="background: #F5F5F5; padding: 5px;" |Symptoms are not related to adrenergic stimuli, | | style="background: #F5F5F5; padding: 5px;" |Symptoms are not related to adrenergic stimuli, | ||
* [[Syncope]] | * [[Syncope]] | ||
* [[Sudden cardiac death]] | * [[Sudden cardiac death]] |
Revision as of 09:34, 30 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from Arrhythmogenic right ventricular dysplasia, Short-coupled ventricular tachycardia (SC-torsade de pointes [TdP]), Long QT syndrome and Andersen-Tawil syndrome.
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases
Catecholaminergic polymorphic ventricular tachycardia must be differentiated from other diseases that cause syncope, ventricular tachycardia, and sudden cardiac death, such as:
- Arrhythmogenic right ventricular dysplasia
- Short-coupled ventricular tachycardia (SC-torsade de pointes [TdP])
- Long QT syndrome
- Andersen-Tawil syndrome
- Brugada syndrome
Differentiating Catecholaminergic polymorphic ventricular tachycardia from other diseases on the basis of syncope, sudden cardiac death, and ventricular tachycardia
On the basis syncope, sudden cardiac death, and ventricular tachycardia, Catecholaminergic polymorphic ventricular tachycardia must be differentiated from Arrhythmogenic right ventricular dysplasia, Short-coupled ventricular tachycardia (SC-torsade de pointes TdP), Long QT syndrome, Andersen-Tawil syndrome and Brugada syndrome.
Diseases | Cause | Clinical manifestations | ECG | Structural abnormalities | |
---|---|---|---|---|---|
ECG during rest | ECG during exercise or stress | ||||
Catecholaminergic polymorphic ventricular tachycardia | Mutations in RYR2 and CASQ2 genes | Symptoms are exercise or emotion related |
|
- | |
Arrhythmogenic right ventricular dysplasia | Usually caused by mutations in genes encoding for desmosomal proteins. | Symptoms are usually exercise-related
Symptoms and signs related to right ventricular failure may also be seen. |
|
Left bundle branch block pattern during tachycardia | It primarily affects the right ventricle (RV). Changes seen are:[1]
|
Short QT syndrome |
|
Symptoms are not exercise-related or triggered
Physical examination is normal. |
|
- | - |
Long QT syndrome | Mutations in genes encoding for sodium and potassium ion channels in the heart. | Symptoms are triggered by exercise, stress, certain drugs, etc |
|
- | |
Andersen-Tawil syndrome | Mutation in KCNJ2 gene. | Symptoms are not related to adrenergic activation
Other significant findings include:
|
|
- | - |
Brugada syndrome | Mutation in SCN5A gene. | Symptoms occur predominantly during sleep or at rest
Other findings: |
- | - | |
Short-coupled ventricular tachycardia
(SC-torsade de pointes TdP) |
Unknown | Symptoms are not related to adrenergic stimuli, |
|
- | - |
References
- ↑ Hundley, W. Gregory; Bluemke, David A.; Finn, J. Paul; Flamm, Scott D.; Fogel, Mark A.; Friedrich, Matthias G.; Ho, Vincent B.; Jerosch-Herold, Michael; Kramer, Christopher M.; Manning, Warren J.; Patel, Manesh; Pohost, Gerald M.; Stillman, Arthur E.; White, Richard D.; Woodard, Pamela K. (2010). "ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance". Circulation. 121 (22): 2462–2508. doi:10.1161/CIR.0b013e3181d44a8f. ISSN 0009-7322.